BioSpace News Archive

Medexus Pharmaceuticals Inc. (the “ Company ” or “Medexus ”) (TSXV: MDP) (OTCQX: MEDXF) (Frankfurt: P731) announced today that it has renewed and expanded its distribution agreement for NYDA ® , a market leading treatment for head lice, through September 26, 2026.

Blue Cross Blue Shield of Massachusetts (“Blue Cross”) today released a new public health messaging video to support the COVID-19 vaccination effort. The 2-minute video , produced by Blue Cross’ health news service Covera

Second Genome, a leader in microbiome science, today announced the appointment of Susannah Cantrell, PhD, to the position of chief business officer, and Preeti G. Lal, PhD, to the position of chief scientific officer.

Mawi DNA Technologies’ iSWAB-Microbiome-EL sample collection technology enables BioTech Africa to implement and launch a new ultra-high throughput COVID-19 testing program.

Iterum Therapeutics plc today announced that the U.S. Food and Drug Administration (FDA) accepted for review the New Drug Application (NDA) for sulopenem etzadroxil/probenecid (oral sulopenem) for the treatment of uncomplicated urinary tract infections (uUTIs) in patients with a quinolone non-susceptible pathogen.

Cyclerion Therapeutics, Inc. (Nasdaq: CYCN), a clinical-stage biopharmaceutical company on a mission to develop treatments that restore cognitive function, today announced the appointment of clinical and scientific advisory boards comprised of academic leaders with expertise in CNS diseases

Advaxis today announces its financial results for the fiscal year ended October 31, 2020 and provides a business update.

Precision BioSciences, Inc. (Nasdaq: DTIL) a clinical stage biotechnology company dedicated to improving life with its wholly proprietary ARCUS ® genome editing platform, today announced it has received a Notice of Allowance from the U.S. Patent and Trademark Office for a patent application covering PBCAR19B, a next-generation, stealth cell, CD19 product candidate for patients with relapsed/refractory (R/R) Non-Hodgkin Lymphoma (NHL). The allo

Novel mechanism of targeting ‘hypoxia’ through HIF-PH inhibitor was studied for the first time in Hospitalised Covid-19 Patients in Mexico

Life Science Intelligence announced that more than 400 innovators, strategics and investors have registered for the Emerging Medtech Summit, which will be held May 11-13, at The Ritz-Carlton, Laguna Niguel Hotel in the beachside community of Dana Point in Southern California.